RVBA-ASTRAPharma Manufacturing

AstraZeneca — in detail

Full extracted data, every event in the company's history we've captured, and (soon) external news. The full ratios diagnostic with peer benchmarks lives at /ratios.

Reference sources (0/5)
  • Source documents
  • Recent disclosure
  • Multi-year metrics
  • Targets
  • Certifications

External news· 11 ESG-tagged · GDELT

tagged categories: climate · governance · controversy · M&A · regulatory

Source: GDELT 2.0 DOC API · ESG-keyword filtered · 3-month trailing window.

Data by year· every metric + key events per year

Each year shows the firm's reported metrics on the left and the most material events on the right. Up to 10 events per year; the full event log is one click further.

2025

P&L highlights (USD)
Headcount (FTE)2,023people
Revenue58.7B
Cost of revenue(10.6B)
Gross profit48.1B
Operating expenses (S&M + G&A)(34.4B)
Operating income13.7B
Net income10.3B
Balance sheet highlights (USD)
Property, plant & equipment14.7B
Total assets114.1B
Total debt27.9B
Cash & equivalents5.7B
Minority interest52M
Market & shares
Market cap (FY-end)272B
Shares outstanding1.6B

2024

P&L highlights (USD)
Headcount (FTE)2,022people
Revenue54.1B
Cost of revenue(10.2B)
Gross profit43.9B
Operating expenses (S&M + G&A)(33.9B)
Operating income10B
Net income7B
Balance sheet highlights (USD)
Property, plant & equipment11.6B
Total assets104B
Total debt28.7B
Cash & equivalents5.5B
Minority interest85M
Market & shares
Market cap (FY-end)201.5B
Shares outstanding1.6B

2023

P&L highlights (USD)
Revenue45.8B
Cost of revenue(8.3B)
Gross profit37.5B
Operating expenses (S&M + G&A)(29.4B)
Operating income8.2B
Net income6B
Balance sheet highlights (USD)
Property, plant & equipment10.5B
Total assets101.1B
Total debt27.5B
Cash & equivalents5.8B
Minority interest23M
Market & shares
Market cap (FY-end)207.4B
Shares outstanding1.6B

2022

P&L highlights (USD)
Revenue44.4B
Cost of revenue(12.4B)
Gross profit32B
Operating expenses (S&M + G&A)(28.2B)
Operating income3.8B
Net income3.3B
Balance sheet highlights (USD)
Property, plant & equipment9.4B
Total assets96.5B
Total debt28.2B
Cash & equivalents6.2B
Minority interest21M
Market & shares
Market cap (FY-end)210.9B
Shares outstanding1.5B

2021

P&L highlights (USD)
Revenue37.4B
Cost of revenue(12.4B)
Gross profit25B
Operating expenses (S&M + G&A)(23.9B)
Operating income1.1B
Net income112M
Balance sheet highlights (USD)
Property, plant & equipment10.2B
Total assets105.4B
Total debt29.7B
Cash & equivalents6.3B
Minority interest19M
Market & shares
Market cap (FY-end)164.3B
Shares outstanding1.4B

2020

P&L highlights (USD)
Revenue26.6B
Cost of revenue(5.3B)
Gross profit21.3B
Operating expenses (S&M + G&A)(16.2B)
Operating income5.2B
Net income3.2B
Balance sheet highlights (USD)
Property, plant & equipment8.9B
Total assets66.7B
Total debt19.7B
Cash & equivalents7.8B
Minority interest16M
Market & shares
Market cap (FY-end)132.5B
Shares outstanding1.3B